Actively managed, multi-sector / jurisdiction portfolio, targeting fast-growing businesses.
A fund with a robust pipeline of new investment opportunities as existing investee companies approach liquidity events.
We aim to grow Seed as a quoted life sciences & technology investment fund and to continue to return value to shareholders.
Proven track record of investments and exits. In 2023/24 we returned value to shareholders via a share buy back programme and a special dividend.
We have a strong team with an extensive international advisory network giving us access to deal flow and investment opportunities.